Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of Clinical Pathways
This comprehensive research highlights favorable outcomes with Cigna’s home-redirection program for pegfilgrastim administration in CIN prophylaxis, including a 32% reduction in specific complications. Explore how this study may influence future healthcare delivery models, enhancing both clinical efficacy and affordability.
Hematology/Oncology August 1st 2023
Pharmacy Practice News
The application of NIOSH Hazardous Drug Assessment principles to home healthcare is a critical development in ensuring safety. As home delivery of treatments like chemotherapy grows, understanding and implementing these principles become vital for healthcare professionals, patients, and their families. Explore how these principles are being adapted to protect all involved in this complex process.
Clinical Pharmacology July 31st 2023